The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
MicroRNA‐146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins
Abstract
Objective: MicroRNA have recently been identified as regulators that modulate target gene expression and are involved in shaping the immune response. This study was undertaken to investigate the contribution of microRNA‐146a (miR‐146a), which was identified in the pilot expression profiling step, to the pathogenesis of systemic lupus erythematosus (SLE). Methods: TaqMan microRNA assays of peripheral blood leukocytes were used for comparison of expression levels of microRNA between SLE patients and controls. Transfection and stimulation of cultured cells were conducted to determine the biologic function of miR‐146a. Bioinformatics prediction and validation by reporter gene assay and Western blotting were performed to identify miR‐146a targets. Results: Profiling of 156 miRNA in SLE patients revealed the differential expression of multiple microRNA, including miR‐146a, a negative regulator of innate immunity. Further analysis showed that underexpression of miR‐146a negatively correlated with clinical disease activity and with interferon (IFN) scores in patients with SLE. Of note, overexpression of miR‐146a reduced, while inhibition of endogenous miR‐146a increased, the induction of type I IFNs in peripheral blood mononuclear cells (PBMCs). Furthermore, miR‐146a directly repressed the transactivation downstream of type I IFN. At the molecular level, miR‐146a could target IFN regulatory factor 5 and STAT‐1. More importantly, introduction of miR‐146a into the patients' PBMCs alleviated the coordinate activation of the type I IFN pathway. Conclusion: The microRNA miR‐146a is a negative regulator of the IFN pathway. Underexpression of miR‐146a contributes to alterations in the type I IFN pathway in lupus patients by targeting the key signaling proteins. The findings provide potential novel strategies for therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
Real-time quantification of microRNAs by stem-loop RT-PCR
Chen, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni178 · Cited by 4,952
Derivation of the sledai. A disease activity index for lupus patients
Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D., Chang, C. H., Austin, A., Bell, A., Bloch, D. A., Corey, P. N., Decker, J. L., et al. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350606 · Cited by 4,570
Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
Mechanisms of type-I- and type-II-interferon-mediated signalling
Platanias, L. C. (2005) · Nature Reviews Immunology · doi:10.1038/nri1604 · Cited by 3,491
Baechler, E. C., Batliwalla, F. M., Karypis, G., Gaffney, P. M., Ortmann, W. A., Espe, K. J., Shark, K. B., Grande, W. J., Hughes, K. M., Kapur, V., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337679100 · Cited by 2,240
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., & Pascual, V. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021553 · Cited by 1,958
Negative regulation of Toll-like receptor-mediated immune responses
Liew, F. Y., Xu, D., Brint, E. K., & O'Neill, L. A. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1630 · Cited by 1,509
miR-181a Is an Intrinsic Modulator of T Cell Sensitivity and Selection
Li, Q.-J., Chau, J., Ebert, P. J. R., Sylvester, G., Min, H., Liu, G., Braich, R., Manoharan, M., Soutschek, J., Skare, P., et al. (2007) · Cell · doi:10.1016/j.cell.2007.03.008 · Cited by 1,157
Toll-like receptors in systemic autoimmune disease
Marshak-Rothstein, A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1957 · Cited by 1,116
Kawai, T., Sato, S., Ishii, K. J., Coban, C., Hemmi, H., Yamamoto, M., Terai, K., Matsuda, M., Inoue, J.-I., Uematsu, S., et al. (2004) · Nature Immunology · doi:10.1038/ni1118 · Cited by 1,033
Barrat, F. J., Meeker, T., Gregorio, J., Chan, J. H., Uematsu, S., Akira, S., Chang, B., Duramad, O., & Coffman, R. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050914 · Cited by 928
Immune Interferon in the Circulation of Patients with Autoimmune Disease
Hooks, J. J., Moutsopoulos, H. M., Geis, S. A., Stahl, N. I., Decker, J. L., & Notkins, A. L. (1979) · New England Journal of Medicine · doi:10.1056/nejm197907053010102 · Cited by 921
Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis
Stanczyk, J., Pedrioli, D. M. L., Brentano, F., Sanchez‐Pernaute, O., Kolling, C., Gay, R. E., Detmar, M., Gay, S., & Kyburz, D. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23386 · Cited by 904
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Kanzler, H., Barrat, F. J., Hessel, E. M., & Coffman, R. L. (2007) · Nature Medicine · doi:10.1038/nm1589 · Cited by 869
Human lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9
Means, T. K., Latz, E., Hayashi, F., Murali, M. R., Golenbock, D. T., & Luster, A. D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523025 · Cited by 849
Pauley, K. M., Satoh, M., Chan, A. L., Bubb, M. R., Reeves, W. H., & Chan, E. K. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2493 · Cited by 766
Gaur, A., Jewell, D. A., Liang, Y., Ridzon, D., Moore, J. H., Chen, C., Ambros, V. R., & Israel, M. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2698 · Cited by 727
Expression of microRNA‐146 in rheumatoid arthritis synovial tissue
Nakasa, T., Miyaki, S., Okubo, A., Hashimoto, M., Nishida, K., Ochi, M., & Asahara, H. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23429 · Cited by 678
Graham, R. R., Kozyrev, S. V., Baechler, E. C., Reddy, M. V. P. L., Plenge, R. M., Bauer, J. W., Ortmann, W. A., Koeuth, T., Escribano, M. F. G., Collaborative Groups, T. A. A. S., et al. (2006) · Nature Genetics · doi:10.1038/ng1782 · Cited by 671
MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets
van Rooij, E., & Olson, E. N. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33099 · Cited by 553
Vollmer, J., Tluk, S., Schmitz, C., Hamm, S., Jurk, M., Forsbach, A., Akira, S., Kelly, K. M., Reeves, W. H., Bauer, S., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051696 · Cited by 513
Uematsu, S., Sato, S., Yamamoto, M., Hirotani, T., Kato, H., Takeshita, F., Matsuda, M., Coban, C., Ishii, K. J., Kawai, T., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042372 · Cited by 488
Feng, X., Wu, H., Grossman, J. M., Hanvivadhanakul, P., FitzGerald, J. D., Park, G. S., Dong, X., Chen, W., Kim, M. H., Weng, H. H., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22044 · Cited by 487
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
Baccala, R., Hoebe, K., Kono, D. H., Beutler, B., & Theofilopoulos, A. N. (2007) · Nature Medicine · doi:10.1038/nm1590 · Cited by 473
Bengtsson, A. A., Sturfelt, G., Truedsson, L., Blomberg, J., Alm, G., Vallin, H., & Rönnblom, L. (2000) · Lupus · doi:10.1191/096120300674499064 · Cited by 464
MicroRNA profiling of the murine hematopoietic system
Monticelli, S., Ansel, K. M., Xiao, C., Socci, N. D., Krichevsky, A. M., Thai, T.-H., Rajewsky, N., Marks, D. S., Sander, C., Rajewsky, K., et al. (2005) · Genome Biology · doi:10.1186/gb-2005-6-8-r71 · Cited by 436
Coordinate overexpression of interferon‐α–induced genes in systemic lupus erythematosus
Kirou, K. A., Lee, C., George, S., Louca, K., Papagiannis, I. G., Peterson, M. G. E., Ly, N., Woodward, R. N., Fry, K. E., Lau, A. Y., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20798 · Cited by 418
The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling
Schoenemeyer, A., Barnes, B. J., Mancl, M. E., Latz, E., Goutagny, N., Pitha, P. M., Fitzgerald, K. A., & Golenbock, D. T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412584200 · Cited by 411
Dai, Y., Huang, Y.-S., Tang, M., Lv, T.-Y., Hu, C.-X., Tan, Y.-H., Xu, Z.-M., & Yin, Y.-B. (2007) · Lupus · doi:10.1177/0961203307084158 · Cited by 356
MicroRNAs and Immunity: Tiny Players in a Big Field
Taganov, K. D., Boldin, M. P., & Baltimore, D. (2007) · Immunity · doi:10.1016/j.immuni.2007.02.005 · Cited by 343
The type I interferon system in systemic lupus erythematosus
Rönnblom, L., Eloranta, M., & Alm, G. V. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21571 · Cited by 341
Cameron, J. E., Yin, Q., Fewell, C., Lacey, M., McBride, J., Wang, X., Lin, Z., Schaefer, B. C., & Flemington, E. K. (2008) · Journal of Virology · doi:10.1128/jvi.02136-07 · Cited by 310
Principles of microRNA regulation of a human cellular signaling network
Cui, Q., Yu, Z., Purisima, E. O., & Wang, E. (2006) · Molecular Systems Biology · doi:10.1038/msb4100089 · Cited by 309
Type I interferon correlates with serological and clinical manifestations of SLE
Dall’Era, M., Cardarelli, P. M., Preston, B. T., Witte, A., & Davis, J. C. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.033753 · Cited by 289
Systemic lupus erythematosus: all roads lead to type I interferons
Pascual, V., Farkas, L., & Banchereau, J. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.09.014 · Cited by 285
Han, G.-M., Chen, S.-L., Shen, N., Ye, S., Bao, C.-D., & Gu, Y.-Y. (2003) · Genes & Immunity · doi:10.1038/sj.gene.6363966 · Cited by 264
Self-citationLiang, M. H., Schur, P. H., Fortin, P., St.Clair, E. W., Balow, J. E., Costenbader, K., Crofford, L., Pablo, P. D., Dooley, M. A., Finckh, A., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21625 · Cited by 263
Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes
Meng, F., Wehbe-Janek, H., Henson, R., Smith, H., & Patel, T. (2008) · Oncogene · doi:10.1038/sj.onc.1210648 · Cited by 244
Wechsler, B., Davatchi, F., Mizushima, Y., Hamza, M., Dilsen, N., Kansu, E., yazici, H., Barnes, C. G., Chamberlain, M. A., James, D. G., et al. (1992) · Rheumatology · doi:10.1093/rheumatology/31.5.299 · Cited by 219
Systemic Lupus Erythematosus: Multiple Immunological Phenotypes in a Complex Genetic Disease
Fairhurst, A., Wandstrat, A. E., & Wakeland, E. K. (2006) · Advances in Immunology · doi:10.1016/s0065-2776(06)92001-x · Cited by 180
Yasuda, K., Richez, C., Maciaszek, J. W., Agrawal, N., Akira, S., Marshak-Rothstein, A., & Rifkin, I. R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6876 · Cited by 179
IRAK-M Is Involved in the Pathogenesis of Early-Onset Persistent Asthma
Balaci, L., Spada, M. C., Olla, N., Sole, G., Loddo, L., Anedda, F., Naitza, S., Zuncheddu, M. A., Maschio, A., Altea, D., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/518259 · Cited by 169
Urinary lipocalin‐2 is associated with renal disease activity in human lupus nephritis
Pitashny, M., Schwartz, N., Qing, X., Hojaili, B., Aranow, C. B., Mackay, M. C., & Putterman, C. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22594 · Cited by 138
Type I Interferon in Systemic Lupus Erythematosus
Crow, M. K. (2007) · Springer eBooks · doi:10.1007/978-3-540-71329-6_17 · Cited by 114
220-plex microRNA expression profile of a single cell
Tang, F., Hájková, P., Barton, S. C., O’Carroll, D., Lee, C. G. L., Lao, K., & Surani, M. A. (2006) · Nature Protocols · doi:10.1038/nprot.2006.161 · Cited by 111
Activation of the STAT1 signalling pathway in lupus nephritis in MRL/lpr mice
Dong, J., Wang, Q.-X., Zhou, C.-Y., Ma, X.-F., & Zhang, Y.-C. (2007) · Lupus · doi:10.1177/0961203306075383 · Cited by 77
Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases
Fujimoto, M. (2004) · International Immunology · doi:10.1093/intimm/dxh030 · Cited by 76
Kuroiwa, T., Schlimgen, R., Illei, G. G., et al. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(02)00022-0 · Cited by 24
Cited by
Epigenetics and gene expression
Gibney, E. R., & Nolan, C. M. (2010) · Heredity · doi:10.1038/hdy.2010.54 · Cited by 1,109
Function of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 Responses
Lu, L.-F., Boldin, M. P., Chaudhry, A., Lin, L.-L., Taganov, K. D., Hanada, T., Yoshimura, A., Baltimore, D., & Rudensky, A. Y. (2010) · Cell · doi:10.1016/j.cell.2010.08.012 · Cited by 849
Biological functions of microRNAs: a review
Huang, Y., Shen, X. J., Zou, Q., Wang, S. P., Tang, S. M., & Zhang, G. Z. (2011) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-010-0050-6 · Cited by 652
MicroRNAs: History, Biogenesis, and Their Evolving Role in Animal Development and Disease
Bhaskaran, M., & Mohan, M. (2014) · Veterinary Pathology · doi:10.1177/0300985813502820 · Cited by 605
Autoimmunity and organ damage in systemic lupus erythematosus
Tsokos, G. C. (2020) · Nature Immunology · doi:10.1038/s41590-020-0677-6 · Cited by 580
Metadata
- Authors
- Tang, Y., Luo, X., Cui, H., Ni, X., Yuan, M., Guo, Y., Huang, X., Zhou, H., de Vries, N., Tak, P. P., Chen, S., & Shen, N.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2009-03-30
- Volume
- 60
- Issue
- 4
- Pages
- 1065-1075
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2096388504
- Cited by
- 735
- References
- 51
- FWCI
- 37.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.